U.S. Markets closed

Rockville biopharma to sell first product on market in 28 years — but not in the U.S.

Sara Gilgore
Rockville biopharma to sell first product on market in 28 years — but not in the U.S.

The company got approval from an international regulatory body to launch its injection treatment for patients with multiple myeloma.